Effects of recombinant tumor necrosis factor (rHuTNFα)on human neutrophils and monocytes: In vitro, ex vivo and in vivo
- 24 April 2009
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 43 (4) , 286-296
- https://doi.org/10.1111/j.1600-0609.1989.tb00301.x
Abstract
In in vitro experiments, tumor necrosis factor (rHuTNF.alpha.) was found to inhibit spontaneous and directecd migration of normal human neutrophils and monocytes. RHuTNF.alpha. showed no chemoattractant activity. In conjunction with a Phase-2 clinical trial, we also studied in vivo rHuTNF.alpha. effects on neutrophil and monocyte number and function. At the time of maximal plasma TNF levels (30 min), marked neutropenia and monocytopenia were observed. Isolated neutrophils were activated for superoxide production but were unable to migrate. Monocyte migration was inhibited at later times. Neutrophil migratory function recovered between 4 and 8 h but was again depressed at 24 h. The data demonstrate the complexity of the response to TNF, comprising direct and indirect effects which are concentration-, time- and place-dependent. They further suggest that the only neutrophils and monocytes available for participation in an anti-tumor activity of TNF in vivo are those present in the tumor at the outset.Keywords
This publication has 52 references indexed in Scilit:
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1988
- Recombinant human tumor necrosis factor α lacks chemotactic activity for human peripheral blood neutrophils and monocytesBiochemical and Biophysical Research Communications, 1988
- Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.Journal of Clinical Investigation, 1987
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.The Journal of Experimental Medicine, 1987
- Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.The Journal of Experimental Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Tumor necrosis factor provokes superoxide anion generation from neutrophilsBiochemical and Biophysical Research Communications, 1986
- Modulating Influence of Chemotactic Factor-Induced Cell Adhesiveness on Granulocyte FunctionJournal of Clinical Investigation, 1979